Promise of epigenetic modulation as a target in atherosclerotic patients.
Topic:
Atherosclerosis
Speaker:
Professor E. Stroes (Amsterdam, NL)
Organised by Physicians' Academy for Cardiovascular Education, supported with an educational grant by Resverlogix
Event:
ESC Congress 2017
Congress Presentation
About the speaker
Professor Erik Stroes
Academic Medical Centre, Amsterdam (Netherlands (The))
39
presentations
0
follower
4 more presentations in this session
Introduction - Managing diabetes & CVD: is epigenetics a new way forward?
Speaker: Professor L. Badimon (Barcelona, ES)
Managing high risk diabetes patient with cardiovascular disease: what works, and what else can we do?
Speaker: Professor R. Kausik
Insights from the first trials in epigenetics in human: what is the way forward?
Speaker: Professor S. Nicholls (Melbourne, AU)
Discussion - Managing diabetes & CVD: is epigenetics a new way forward?
Speaker: Professor R. Kausik
Access the full session
Managing diabetes & cardiovascular disease (CVD): is epigenetics a new way forward? (EBAC Accredited)
Speakers:
Professor E. Stroes, Professor L. Badimon, Professor R. Kausik, Professor S. Nicholls, Professor R. Kausik
About the event
ESC 365 is supported by
